| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
The United States "desperately" needs more tests to screen for the new coronavirus, a public health expert told Congress on Friday.[CR-LF][CR-LF]"Testing capacity is not currently adequate, and we need more," said Dr. Lisa Maragakis, senior director of infection prevention for the Johns Hopkins Health System and an epidemiologist. "We need this as soon as we can have it."[CR-LF][CR-LF]Maragakis' remarks were part of a briefing on Capitol Hill by five experts from Johns Hopkins, which has been tracking the international outbreak.
The Trump administration has faced criticism over the availability of coronavirus test kits in the United States. Vice President Mike Pence has said any American would be able to get tested for the disease it causes, COVID-19 — but acknowledged this week, as the government raced to distribute tests, that the capacity wasn't there yet.[CR-LF][CR-LF]So what should someone do if they want to get tested?[CR-LF][CR-LF]According to the American Hospital Association, people who think they have the coronavirus should call their physician to see if a test is warranted. If so, they will direct you to an appropriate testing site.
The administration is working to quickly expand testing by making the kits more readily available to state and local laboratories across the country as the case count increases, particularly among patients who did not travel to China — the origin of the outbreak — and have no direct link to travelers.[CR-LF][CR-LF]Initially, the government limited the testing to only those exhibiting symptoms of the virus who had also traveled to China. The tests were only being performed in a handful of laboratories in certain states at first.
Public health officials have been clamoring for greater testing capacity to help them combat the spread of the new coronavirus in their communities. Now, as testing is poised to become more widely available from commercial labs, the cost of those diagnostic tests could become a factor in the effort to control the virus.[CR-LF][CR-LF]Lab Corp. announced Thursday it was immediately offering testing for COVID-19, while Quest Diagnostics said it will start testing specimens next week, increasing the options for hospitals, physicians offices and urgent care clinics.
President Trump, on a visit to the Centers for Disease Control in Atlanta, asserted that coronavirus tests are available to "anybody." "Anybody that wants a test can get a test," he said. "That's what the bottom line is."[CR-LF][CR-LF][CR-LF]And he added, "Anybody right now and yesterday, anybody that needs a test gets a test. They're there. They have the tests and the tests are beautiful. Anybody that needs a test gets a test. If there's a doctor that wants to test, if there's somebody coming off a ship like the big monster ship that's out there right now, which you know again, that's a big decision. Do I wanna bring all of those people on? People would like me to do that. I don't like the idea of doing it."
New coronavirus cases emerge across the country. Michigan is the biggest of the six primary states voting next week. And, a cease-fire between Turkey and Russia is in effect in northwestern Syria.
Nearly a week after the first U.S. coronavirus death was announced, the Trump administration scrambled Friday to meet its target for increasing the number of people able to be tested. But it still could take weeks for the actual tests to take place.[CR-LF][CR-LF]HHS Secretary Alex Azar told reporters that the government had shipped out materials for 700,000 coronavirus tests — well short of the 1.5 million that Vice President Mike Pence had said would be available to hospitals this week, in remarks on Wednesday. Late Friday, Assistant Secretary for Health Brett Giroir told POLITICO that more tests passed quality checks, bringing the total ready to 1.5 million.
Hospitals across the state are preparing for an influx of people wondering whether they’ve contracted coronavirus by making plans for “triage centers” outside their main buildings.[CR-LF][CR-LF]The centers could be tents in hospital parking lots, or temporary trailers or office space, not necessarily near the hospitals that would open them.[CR-LF][CR-LF]The extra infrastructure would be used primarily for screening and testing, not treatment, in order to keep people who think they may have contracted the COVID-19 coronavirus out of waiting rooms and emergency departments where people with otherwise compromised immune systems might be.
Dr. Amy Compton-Phillips recalled the day the first U.S. patient infected with COVID-19, a 35-year-old man from Snohomish County in Washington state, had taken a “turn for the worse.”[CR-LF][CR-LF]“He was day nine in his course and he actually started going downhill, started getting worse,” said Compton-Phillips, chief clinical officer of Providence St. Joseph Health, where the patient was treated.[CR-LF][CR-LF]At first, the patient only had common cold-like symptoms, Compton-Phillips said. But very quickly he began to have shortness of breath and a cough, she said. His X-ray also showed viral pneumonia. He needed supplemental oxygen and had to be put on an experimental antiviral treatment.
Connecticut lawmakers will begin the daunting task Friday of crafting a strategy to mobilize the public and private sectors to combat the coronavirus – an effort that comes as state health officials acknowledged hundreds of residents are being monitored for the illness.[CR-LF][CR-LF]The state Department of Public Health is aware of 200 people currently being monitored for the virus, said Max Reiss, spokesman for Gov. Ned Lamont. The governor was briefed Thursday by Renee Coleman-Mitchell, commissioner of the state Department of Public Health, and Dr. Matthew Carter, the state epidemiologist.
A major health insurance trade group is pledging its member plans will cover doctor-ordered testing for the coronavirus amid rising confusion and concern about who will bear the cost of care in an outbreak.
U.S. Sen. Bob Menendez on Thursday joined with 14 Senate colleagues to urge U.S. employers to commit not to penalize workers for following recommended health procedures in order to protect the public from further spread of the coronavirus.[CR-LF][CR-LF]In a letter to major industry groups, which together represent thousands of companies employing millions of Americans, the senators wrote: “As the United States mobilizes to respond to the recent outbreak and spread of COVID-19, the novel coronavirus, we write to urge your member companies to prioritize their employees’ health, economic well-being, and security during this response. The companies you represent are some of the largest, most high profile companies in the United States. The broader business community watches their actions closely and we believe they have an opportunity, and an obligation, to lead in this moment.”
U.S. lab operator Quest Diagnostics Inc said on Thursday it was launching a test service for coronavirus and can start testing from next week.[CR-LF][CR-LF]On Wednesday, the Trump administration met with private lab test developers to discuss increasing the availability of diagnostics.[CR-LF][CR-LF]The company said test services will be provided as a laboratory developed test, pending review by the FDA under emergency-use authorization.
Trump administration officials doubled down on their promise to deliver 1 million tests for the coronavirus this week as states reported limited testing supplies and federal lawmakers expressed doubts about the government's timeline.[CR-LF][CR-LF]Health and Human Services Secretary Alex Azar told reporters Thursday that a private manufacturer authorized to make the tests expects to ship the kits to U.S. laboratories by week's end. That amounts to the capacity to test roughly 400,000 people, given that it takes multiple test samples to a confirm a result.
Secaucus-based Quest Diagnostics, a provider of diagnostic information services, said Thursday it will launch a coronavirus test service.[CR-LF][CR-LF]The new test service aids the presumptive detection of nucleic acid in respiratory specimens of patients meeting CDC’s clinical criteria for COVID-19 testing. Quest will be in position to receive specimens for testing and begin to provide testing on March 9.
Quest Diagnostics, one of the largest commercial lab companies in the country, announced on Thursday it is launching a laboratory-developed test for the coronavirus next week, but it is unclear how many tests it will be able to run or how much it will cost. A spokesperson told POLITICO the test is in the process of being validated at Quest’s lab in San Juan Capistrano, Calif.
Quest Diagnostics plans to launch a nationwide testing service for the novel coronavirus next week—moving forward with its own assay after the FDA gave companies the green light to proceed with validated tests before receiving any agency review or authorizations.[CR-LF][CR-LF]The company described its lab-developed, molecular-based test as designed to detect viral RNA in respiratory specimens, and that it will be used for presumptive detection of the disease known as COVID-19.[CR-LF][CR-LF]Quest said it plans to begin receiving and testing specimens March 9, and will work to submit its test for agency review within the mandated 15-day timeline.
On Thursday, the total number of confirmed cases of COVID-19 in the U.S. that had been reported to the Centers for Disease Control (CDC) swelled to 100 -- and next week, that number is probably going to climb much further. That's because the country's second-largest provider of clinical testing services, Quest Diagnostics (NYSE:DGX), has announced plans to begin helping the CDC unwind its backlog of coronavirus tests.[CR-LF][CR-LF]During January and February, U.S. healthcare officials isolated some people at risk of carrying SARS-CoV-2, the virus that causes COVID-19. Unfortunately, a shortage of fully approved testing kits means that it's still unclear how many infected individuals may have slipped through the cracks. It's fairly likely to be a large number. In the past two months, just a few thousand people with suspected cases of COVID-19 were actually tested in the U.S.
Lab operators Quest Diagnostics Inc and OPKO Health Inc said on Thursday they would be able to begin testing for coronavirus from next week, as the U.S. government ramps up efforts to increase diagnostic capabilities.
Despite intense scrutiny and criticism of the diagnostic testing rollout in the US for the SARS-CoV-2 virus, the emergency regulatory process may actually be proceeding at a much more rapid pace than past emergencies, which did not involve newly-emerged pathogens.[CR-LF][CR-LF]Commercial tests in development to date have faced bottlenecks in test validation, but the logjam now appears to be clearing with new US Food and Drug Administration feedback and the availability of control materials.
After a weekslong delay, thousands of coronavirus test kits are headed to state and local laboratories, Vice President Mike Pence said Wednesday.[CR-LF][CR-LF]But questions remain about when, exactly, those promised test kits will arrive and how well they will work.
The Trump administration met with private lab test developers on Wednesday to discuss increasing the availability of tests for the coronavirus and said that the companies had formed a consortium. Vice President Mike Pence said the U.S. Department of Health and Human Services has included coronavirus testing as an essential health benefit for health plans in a bid to increase Americans’ access to tests.[CR-LF][CR-LF]“We want every American to have access to testing,” Pence said.
Thanks, Mr. Vice President. I appreciate the opportunity and your leadership on this matter. We understand this a public health issue that we all have a role in, and we’re deeply committed to working through this together.[CR-LF][CR-LF]We also appreciate the support of the FDA and the Centers for Disease Control. They’ve been very good partners in this regard. And particularly over the weekend — the decision that was made to give us — a decision that accelerated our path to bringing tests to the market place. As Adam said, we’re validating it as we speak. And, hopefully, by the next week, we’ll able to ramp that up at a number of our laboratories throughout this country.
President Trump and Vice President Pence hold a White House briefing with airline CEOs and diagnostic lab CEOs on coronavirus. There are at least 100 confirmed cases in the country, along with nine deaths, but some experts have suggested that the real number may be considerably higher if testing is expanded.
Following ongoing developments related to COVID-19 testing and response, included below is a statement from ACLA President Julie Khani following today’s meeting with the White House’s Coronavirus Task Force:[CR-LF][CR-LF]“We appreciated the opportunity to meet with Vice President Pence and members of the White House’s Coronavirus Task Force this afternoon on the critical issues related to testing capacity. As an industry, clinical labs have taken steps to meet the growing demand for national testing and are working together with the Administration, the CDC and FDA as well as state and local public health labs, hospitals and academic medical centers.